Tremfya, for lasting consistent joint and skin relief & Tremfya, an IL23 inhibitor for Pso and PsA.

Back to Janssen Medical Cloud

Home
Safety
Efficacy
Dosing and administration
Supporting materials
Back
Supporting materials
- Supporting materials
- Mode of Action
EULAR-2024
IL23

CP-399765 - August 2023

© Janssen-Cilag NV 2021. This site is published by Janssen-Cilag NV which is solely responsible for its content. It is intended for Healthcare professionals in Belgium and Luxembourg.

Privacy Policy Legal Notice Cookie Policy

Cookie Settings